Anti-prostate cancer protection and therapy in the framework of predictive, preventive and personalised medicine - comprehensive effects of phytochemicals in primary, secondary and tertiary care.

Mazurakova, Alena; Samec, Marek; Koklesova, Lenka; Biringer, Kamil; Kudela, Erik; Al-Ishaq, Raghad Khalid; Pec, Martin; Giordano, Frank A; Büsselberg, Dietrich; Kubatka, Peter; Golubnitschaja, Olga

Mazurakova, Alena; Samec, Marek; Koklesova, Lenka; Biringer, Kamil; Kudela, Erik; Al-Ishaq, Raghad Khalid; Pec, Martin; Giordano, Frank A; Büsselberg, Dietrich; Kubatka, Peter; Golubnitschaja, Olga.

Affiliation

Mazurakova A; Clinic of Obstetrics and Gynecology, Jessenius Faculty of Medicine, Comenius University in Bratislava, 036 01 Martin, Slovakia.
Samec M; Department of Pathological Physiology, Jessenius Faculty of Medicine, Comenius University in Bratislava, 036 01 Martin, Slovakia.
Koklesova L; Clinic of Obstetrics and Gynecology, Jessenius Faculty of Medicine, Comenius University in Bratislava, 036 01 Martin, Slovakia.
Biringer K; Clinic of Obstetrics and Gynecology, Jessenius Faculty of Medicine, Comenius University in Bratislava, 036 01 Martin, Slovakia.
Kudela E; Clinic of Obstetrics and Gynecology, Jessenius Faculty of Medicine, Comenius University in Bratislava, 036 01 Martin, Slovakia.
Al-Ishaq RK; Department of Physiology and Biophysics, Weill Cornell Medicine-Qatar, Qatar Foundation, Education City, Doha, Qatar.
Pec M; Department of Medical Biology, Jessenius Faculty of Medicine, Comenius University in Bratislava, 036 01 Martin, Slovakia.
Giordano FA; Department of Radiation Oncology, University Hospital Bonn, Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn, Germany.
Büsselberg D; Department of Physiology and Biophysics, Weill Cornell Medicine-Qatar, Qatar Foundation, Education City, Doha, Qatar.
Kubatka P; Department of Medical Biology, Jessenius Faculty of Medicine, Comenius University in Bratislava, 036 01 Martin, Slovakia.
Golubnitschaja O; Predictive, Preventive and Personalised (3P) Medicine, Department of Radiation Oncology, University Hospital Bonn, Rheinische Friedrich-Wilhelms-Universität Bonn, 53127 Bonn, Germany.

EPMA J ; 13(3): 461-486, 2022 Sep.

Article de En | MEDLINE | ID: mdl-35821883

Mots clés

Anti-cancer protection; COVID-19; Clinical trials; Cost-efficacy; Health policy; Health-to-disease transition; Metastatic disease; Mitochondrial health; Molecular mechanisms; Phenotyping; Phytochemicals; Plant-based food; Predictive Preventive Personalised Medicine (PPPM/3PM); Primary secondary tertiary care; Prostate cancer management; ROS; Radiation and chemotherapy; Risk assessment; Silibinin; Stress; Sub-optimal health condition; Tailored treatments

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Prognostic_studies / Risk_factors_studies Langue: En Journal: EPMA J Année: 2022 Type de document: Article Pays d'affiliation: Slovaquie Pays de publication: Suisse

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google